| Date | Title | Description |
| 11.03.2026 | Ibex Medical Analytics and mTuitive Forge Partnership to Revolutionize Pathology with AI-Powered Structured Reporting | Integration Delivers Seamless Workflow Combining AI-Powered Cancer Diagnosis with CAP, RCPath, and ICCR-Compliant Structured Reporting
By creating a unified environment where mTuitive structured reporting meets Ibex real-time AI insights, t... |
| 25.03.2025 | Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care | - |
| 09.12.2024 | The Digital Revolution in Pathology: A New Dawn for Patient Care | In the world of healthcare, time is often the most precious commodity. For patients facing the specter of cancer, every moment counts. The journey from detection to diagnosis can feel like an eternity. As technology advances, the integratio... |
| 09.12.2024 | The Role of AI-Enabled Pathology in Enhancing Patient Care | Joseph Mossel, Ibex Medical Analytics’ CEO
There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In this process, once a clinician has determined a need for a... |
| 12.07.2024 | Philips IntelliSite Pathology Solution Receives 510(k) Clearance | What You Should Know:
– Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally.
– With over 300 pathology ... |
| 07.03.2024 | Ibex and PathPresenter Launch Partnership to Accelerate Adoption of AI-powered Digital Pathology | PathPresenter and Ibex Partner to Advance Digital Pathology and AI Solutions
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and PathPresenter, the global image sharing platform for pathology, announced a partner... |
| 30.11.2023 | Dedalus, Ibex Launches AI-powered Digital Pathology Solution for Cancer Diagnosis | Ibex Logo
What You Should Know:
– Dedalus Group, an anatomic pathology information systems provider in Europe, and Ibex Medical Analytics, a market leader in AI-powered cancer diagnostics, have jointly launched an integrated End-to-End AI-p... |
| 08.09.2023 | Ibex closes $55m Series C financing round | - |
| 08.09.2023 | Ibex Launches Breast Cancer Biomarker Diagnostic Platform | What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.
Gale... |
| 06.09.2023 | Ibex Medical Analytics Raises $55M to Drive AI for Cancer Diagnosis Adoption Globally | What You Should Know:
– Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North.
– The round also included participation from Sienna Venture Capital and existing inve... |
| 06.09.2023 | Ibex Medical Analytics Raises $55M in Series C Funding | Ibex Medical Analytics, a Tel Aviv, Israel-based company advancing AI-powered cancer diagnostics, raised $55M in Series C funding.
The round, which brought the total amount to $100M since its inception in 2016, was led by 83North. Other par... |
| 06.09.2023 | Ibex Medical raises $55 million Series C for AI-powered cancer diagnostics | - |
| 14.12.2022 | Ibex Study Finds AI Highly Accurate in Cancer Identification | What You Should Know:
– The algorithm accurately identified invasive carcinoma and ductal carcinoma in situ (DCIS) with 93.79% specificity and 93.20% sensitivity. Additionally, the AI differentiated well between different grades and subtype... |
| 14.12.2022 | Ibex Deploys AI-powered Cancer Diagnostics Solution at UPMC | Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, announced the live deployment by the University of Pittsburgh Medical Center (UPMC) of Galen Prostate, an AI-based solution that supports pathologists during cancer... |
| 07.12.2022 | Leading UK Diagnostics Provider Source LDPath Expands AI Capabilities with Ibex Medical Analytics | Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics and Source LDPath, a part of Source BioScience (Source), a leading international provider of integrated state-of-the-art laboratory services and products, announced ... |
| 07.12.2022 | Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics | NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics and Source LDPath, a part ... |
| 10.11.2022 | Ibex Medical Analytics Raises $10M in Debt Funding | Ibex Medical Analytics, a Tel Aviv, Israel-based AI-powered cancer diagnostics company, raised $10M in debt funding.
The round was led by Kreos Capital.
The company intends to use the funds to strengthen and expand its US team and support n... |
| 09.11.2022 | Ibex Medical Analytics Secures $10 Million Funding from Kreos Capital | Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, announced it had secured $10 million in funding from Kreos Capital.
The announcement follows a major expansion of Ibex’s commercial footprint over the past few mont... |
| 04.09.2022 | Ibex Announces Galen™ 3.0 Cancer Diagnostics Platform | Latest version of Galen™ transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user-interface, and workflow integration capabilities
TEL AVIV, Israel, Sept. 4, 2022 /PRNewswire/ -- Ibex Medical Analyti... |
| 19.10.2021 | Israeli startup Ibex Medical aims to transform cancer diagnostics with AI tech | Advanced technologies such as artificial intelligence (AI) and machine learning have been reshaping the healthcare landscape, introducing new processes in fields like medical imaging, disease screening and diagnosis, drug discovery and deve... |
| 14.09.2021 | Ibex Expands United States Operations: Appointing Douglas Clark MD, as Chief Medical Officer, Americas; CEO Relocating to Lead U.S. Headquarters
USA - English USA - English | |
| 11.08.2021 | Alverno Laboratories Selects Ibex’s AI Solution for Cancer Diagnostics | Alverno will deploy Ibex’s AI-powered Galen platform, supporting pathologists in improving the quality of cancer diagnosis
Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated labora... |
| 08.07.2021 | Ibex And Sana Kliniken Berlin-Brandenburg Partner To Bring AI-powered Cancer Diagnostics To Germany | Sana Kliniken Berlin-brandenburg Will Deploy Ibex’s AI-powered Galen™ Platform, Helping Pathologists Provide Accurate Diagnosis And Improved Care For Cancer Patients
Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powere... |
| 09.06.2021 | Ibex Granted FDA Breakthrough Device Designation | Ibex’s Galen™ AI-powered platform is recognized by the FDA as breakthrough technology with the potential to more effectively diagnose cancer
Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, announced the granting of Bre... |
| 09.06.2021 | Ibex Granted FDA Breakthrough Device Designation
USA - English USA - English | |
| 18.03.2021 | Ibex’s Daphna Laifenfeld On AI-Powered Cancer Diagnostics, Company Raising $38 Million In Series B Funding And The Future Of Personalized Medicine | Daphna Laifenfeld, Ibex’s Chief Scientific OfficerIbex Medical Analitycs |
| 11.03.2021 | Ibex Medical Analytics lands $38M Series B | Tel Aviv-based Ibex Medical Analytics has secured $38 million in a round led by Octopus Ventures and 83North. The startup provides AI- and machine learning-backed tools to help doctors diagnose cancer more accurately and efficiently. The Se... |
| 10.03.2021 | London-based Octopus Ventures and 83North back cancer diagnostics AI startup from Israel in £27.3M funding round | The London-based most prominent venture capital firm, Octopus Ventures and 83North recently backed the AI-powered cancer diagnostics startup from Israel – Ibex Medical Analytics – in a £27.3 million Series B funding round.
Along with Octopu... |
| 10.03.2021 | Ibex Medical Analytics draws $38M Series B to expand its AI pathology platforms | |
| 10.03.2021 | Ibex Medical Analytics Raises $38M in Series B Funding | Ibex Medical Analytics, a Tel Aviv, Israel-based AI-powered cancer diagnostics company, raised $38m in Series B financing.
The round was led by Octopus Ventures and 83North, with participation from aMoon, Planven Entrepreneur Ventures and D... |
| 09.03.2021 | Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform | Israel-based Ibex Medical Analytics, which has an AI-driven imaging technology to detect cancer cells in biopsies more efficiently, has raised a $38 million Series B financing round led by Octopus Ventures and 83North. Also participating in... |
| 09.03.2021 | Ibex raises $38M for AI that diagnoses diseases | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Ibex Medical Analytics, a Tel Aviv, Israel-based startup developing a product suite for clinical decision-making and pathology laborato... |
| 09.03.2021 | Ibex Medical Analytics raises $38m for its AI-powered cancer diagnostic platform | Israel-based Ibex Medical Analytics, which has an AI-driven imaging technology to detect cancer cells in biopsies more efficiently, has raised a $38 million Series B financing round led by Octopus Ventures and 83North. Also participating in... |
| 09.03.2021 | Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-Powered Cancer Diagnostics in Pathology | Ibex’s AI technology helps physicians and providers diagnose cancer with greater real-time accuracy by reducing error and misdiagnosis
Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, announced a $38 million Series B fi... |
| 09.03.2021 | Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-powered Cancer Diagnostics in Pathology
USA - English
USA - English | |
| 09.03.2021 | Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform | - |
| 09.03.2021 | Ibex raises $38M for AI that diagnoses diseases | Join Transform 2021 for the most important themes in enterprise AI & Data. Learn more.
Ibex Medical Analytics, a Tel Aviv, Israel-based startup developing a product suite for clinical decision-making and pathology laboratory workflows, ... |
| 09.03.2021 | Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform | - |
| 09.03.2021 | Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-powered Cancer Diagnostics in Pathology | TEL AVIV, Israel, March 9, 2021 /PRNewswire/ -- Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, today announced a $38 million Series B financing round led by Octopus Ventures and 83North, with additional participation ... |
| 09.03.2021 | Tel Aviv-based Ibex Medical Analytics raises $38 million, pushes forward with AI powered cancer diagnostics | Ibex Medical Analytics has recently announced the successful close of Series B financing, to the tune of $38 million.
The round was led by Octopus Ventures and 83North, with aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital... |
| 07.01.2021 | AI Cancer Diagnostics Leader Ibex Medical Analytics Expands to the Americas with Appointment of Joel Duckworth
USA - English
USA - English | |
| 10.12.2020 | U.K. Invests $330 Million To Lead The World In Healthcare AI | In September 2020, NHSX, the organisation driving the digital transformation of health and social ... [+] care, announced that 42 tech companies will receive a share of over £50 million in phase one of its £140m AI in Health and Care Award.... |
| 01.07.2020 | Israeli AI diagnostics firm Ibex to roll out cancer screening for NHS patients in the UK | Israeli AI-powered cancer diagnostics company Ibex Medical Analytics is partnering with UK pathology services provider LDPath to roll out the first clinical-grade AI applications for cancer detection for NHS patients, the parties announced ... |
| 30.06.2020 | ‘Covid Put Everything On Steroids,’ Says Prominent Healthtech Investor | When VC aMoon was established in 2017, “the premise was to invest heavily in the convergence of technology and biology, healthcare and data,” says Dr. Yair Schindel, its Managing Partner. Schindel and Marius Nacht, the other founder of the ... |
| 09.06.2020 | Top 10 companies that have raised funding in the men's health space | While funding women's health startups is rising, men's health so far isn't seeing the same boost
Funding for women's health startups is on the rise after traditionally lagging behind. While that's a great thing, the same can't be said for s... |
| 26.03.2019 | Computational Pathology Pioneer Ibex Raises $11M | - |
| 20.03.2019 | Ibex Medical nabs $11M Series A | Ibex Medical Analytics has secured an $11 million investment in an aMoon-led round. Dell Technologies Capital supported the fundraise, which the Israeli cancer diagnosis startup will use to expand its product offering.
View details |
| - | FDA clears wearable 3D ultrasound for breast imaging | iSono Health’s ATUSA imaging system is the world’s first automated, wearable 3D breast ultrasound, the company said.
With 1 in 8 women in the U.S. developing breast cancer in her lifetime and pathologists in short supply, there’s been a foc... |
| - | Ibex’s AI-Powered Cancer Diagnostics Solution Obtains CE Mark | What You Should Know: |
| - | Deciphex scores $11.5M in bid to address pathologist shortage | As cancer rates continue to rise, there’s an increasing focus on early detection to save lives. But the very specialists that help with just that—pathologists, who study and diagnose diseases including cancer—have declined in number, and th... |
| - | Paige launches software to help detect breast cancer that has spread to the lymph nodes | Paige Breast Lymph Node was designed to help pathologists detect breast cancer that has spread to the lymph nodes.
Cancer screening is vital in detecting potentially life-threatening malignancies early. But research shows that the number of... |
| - | Ibex Medical Analytics | “Trusted Cancer Diagnostics for All” |
